Your browser doesn't support javascript.
loading
Is very high platelet count always associated with essential thrombocythemia? An unusual presentation in a child.
Aktekin, Elif Habibe; Yazici, Nalan; Kozanoglu, Ilknur; Erbay, Ayse.
Afiliação
  • Aktekin EH; Department of Pediatrics Division of Pediatric Hematology-Oncology, Baskent University, Adana, Turkey.
  • Yazici N; Department of Pediatrics Division of Pediatric Hematology-Oncology, Baskent University, Adana, Turkey.
  • Kozanoglu I; Department of Physiology and the Apheresis Unit Adult Bone Marrow Transplant Centre, Baskent University, Adana, Turkey.
  • Erbay A; Department of Pediatrics Division of Pediatric Hematology-Oncology, Baskent University, Adana, Turkey.
Lab Med ; 54(6): e170-e176, 2023 Nov 02.
Article em En | MEDLINE | ID: mdl-37352366
Myeloproliferative neoplasms are rare in childhood. They are categorized as Philadelphia chromosome-positive and Philadelphia chromosome-negative. Chronic myeloid leukemia (CML) is the most common myeloproliferative disease in which the Philadelphia chromosome is detected as a result of BCR-ABL rearrangements. In others, the most common genetic abnormality is JAK2V617F mutation. The coexistence of these 2 abnormalities in CML is unexpected, and rare cases have recently been reported in adults. We present a child who had a very high platelet count in which we found this coexistence. The clinical presentation, laboratory findings, management, and prognosis of this coexistence is challenging in such a rare condition.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Trombocitemia Essencial / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Trombocitemia Essencial / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article